Gavin Macbeath - Net Worth and Insider Trading
Gavin Macbeath Net Worth
The estimated net worth of Gavin Macbeath is at least $274,714 dollars as of 2024-09-20. Gavin Macbeath is the Chief Scientific Officer of TScan Therapeutics Inc and owns about 49,767 shares of TScan Therapeutics Inc (TCRX) stock worth over $274,714. Details can be seen in Gavin Macbeath's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gavin Macbeath has not made any transactions after 2021-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gavin Macbeath
Gavin Macbeath Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gavin Macbeath owns 1 companies in total, including TScan Therapeutics Inc (TCRX) .
Click here to see the complete history of Gavin Macbeath’s form 4 insider trades.
Insider Ownership Summary of Gavin Macbeath
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2021-09-21 | Chief Scientific Officer |
Gavin Macbeath Latest Holdings Summary
Gavin Macbeath currently owns a total of 1 stock. Gavin Macbeath owns 49,767 shares of TScan Therapeutics Inc (TCRX) as of September 21, 2021, with a value of $274,714.
Latest Holdings of Gavin Macbeath
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2021-09-21 | 49,767 | 5.52 | 274,714 |
Holding Weightings of Gavin Macbeath
Gavin Macbeath Form 4 Trading Tracker
According to the SEC Form 4 filings, Gavin Macbeath has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 5,000 shares on September 21, 2021, which cost Gavin Macbeath around $31,100.
Insider Trading History of Gavin Macbeath
- 1
Gavin Macbeath Trading Performance
GuruFocus tracks the stock performance after each of Gavin Macbeath's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gavin Macbeath is -24.65%. GuruFocus also compares Gavin Macbeath's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gavin Macbeath within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gavin Macbeath's insider trading performs compared to the benchmark.
Performance of Gavin Macbeath
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.79 | | | | | |
| Relative Return to S&P 500(%) | 18.3 | | | | | |
Gavin Macbeath Ownership Network
Gavin Macbeath Owned Company Details
What does TScan Therapeutics Inc do?
Who are the key executives at TScan Therapeutics Inc?
Gavin Macbeath is the Chief Scientific Officer of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Legal Officer Zoran Zdraveski , Chief Accounting Officer Leiden Dworak , and 10 percent owner Weston Nichols .
TScan Therapeutics Inc (TCRX) Insider Trades Summary
Over the past 18 months, Gavin Macbeath made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net purchase of 15,000 shares made by Barbara Klencke , and a net sale of 164,686 shares made by Zoran Zdraveski .
In summary, during the past 3 months, insiders sold 164,686 shares of TScan Therapeutics Inc (TCRX) in total and bought 10,000 shares, with a net sale of 154,686 shares. During the past 18 months, 190,086 shares of TScan Therapeutics Inc (TCRX) were sold and 82,027 shares were bought by its insiders, resulting in a net sale of 108,059 shares.
TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TScan Therapeutics Inc Insider Transactions
Gavin Macbeath Mailing Address
Above is the net worth, insider trading, and ownership report for Gavin Macbeath. You might contact Gavin Macbeath via mailing address: C/o Abpro Corporation, 65 Cummings Park Drive, Woburn Ma 01801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
